Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have Hsp70 protein binding activity; chaperone binding activity; and low-density lipoprotein particle receptor binding activity. Predicted to localize to cytoplasm. Is expressed in dorsal root ganglion; facial ganglion; glossopharyngeal ganglion; trigeminal ganglion; and vagus ganglion. Used to study Charlevoix-Saguenay spastic ataxia. Human ortholog(s) of this gene implicated in Charlevoix-Saguenay spastic ataxia. Orthologous to human SACS (sacsin molecular chaperone).